BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BioMedical Enterprises, Inc. Announces U.S. Launch of the OSSAnchor(TM) Grip Nitinol Soft Tissue Anchor


6/4/2008 10:36:01 AM

SAN ANTONIO, June 2 /PRNewswire/ -- BME (BioMedical Enterprises, Inc.), a privately held medical device company and leader in orthopaedic shape memory implant technology, today announced the launch of the OSSAnchor(TM) Grip, a nitinol implant designed to approximate soft tissue to bone.

The Grip is the first in the family of OSSAnchor(TM) nitinol soft tissue implants, designed to secure soft tissue to bone. The Grip is a nitinol implant with aggressive barbs on the legs for bone adhesion, and teeth on the underside of the implant for grasping of soft tissue. The Grip is ideal for upper and lower extremity soft tissue procedures, such as the Achilles tendon reattachment, anterior cruciate ligament reconstruction, and biceps tenodesis.

Made of nitinol, a biocompatible alloy possessing shape memory and super- elastic properties, the OSSAnchor(TM) Grip implant is inserted at room temperature. Using BME's patented OSSforce(TM) Implant Controller, the implant is safely heated above body temperature. During this process, the implant's legs change shape to anchor into bone. In addition, the movement of the legs pulls the bridge of the staple down onto the tendon securing it against bone. After heating, the nitinol structure transforms into a state approximately 20% stronger than 316L stainless steel. Due to nitinol's unique properties, the implant continues to maintain an anchoring compressive force in bone over time.

The OSSAnchor(TM) Grip is also the first orthopaedic nitinol implant to feature barbs for improved pull-out resistance, a new surface treatment that minimizes nickel release, and a roughened surface texture for bone in-growth.

The OSSAnchor(TM) Grip implant was showcased by BME at the Texas Orthopaedic Association's Annual Meeting held May 22-24, in San Antonio, Texas. A national launch will take place at the American Orthopaedic Foot and Ankle Society summer meeting in Denver, Colorado being held June 25-28.

BME is a medical device company that addresses the changing needs in musculoskeletal medicine. BME focuses on minimally invasive orthopaedic instrumentation and implants that elicit a biologic response. BME's focus on memory metal internal fixation implants is changing the shape of orthopaedic medicine. Its specialized history of musculoskeletal research services will continue to produce unique, state of the art orthopaedic products that provide better outcomes for patients and more convenience to surgeons. For more information visit http://www.bme-tx.com.

CONTACT: Eric Marcano, Marketing Manager of BioMedical Enterprises, Inc.
[BME], 1-800-880-6528, Fax, 1-866-913-3977

Web site: http://www.bme-tx.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES